ArticleFrontiers in pharmacology2026
Amiodarone-induced granulomatous lung injury mimicking organizing pneumonia: a case report.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Amiodarone-induced pulmonary toxicity (APT) has a broad clinical spectrum, and its radiologic and histopathologic appearances vary considerably. Granulomatous lung injury, however, is rarely described and may be confused with organizing pneumonia (OP) or infection. Case presentation: An elderly man who had been receiving 5-month amiodarone therapy developed a 3-week history of pleuritic chest pain and progressive dyspnea. Chest computed tomography (CT) demonstrated bilateral ground-glass opacities and subpleural-predominant consolidations, with scattered reversed halo signs raising the possibility of an OP-like pattern. A positive serum Cryptococcal antigen (CrAg) result obtained at an outside hospital led to empiric antifungal therapy, but the patient did not improve. After admission, bronchoalveolar lavage (BAL) revealed lymphocytosis, and metagenomic testing did not detect Cryptococcus or other pathogens; fungal stains on biopsy specimens were also negative. Percutaneous lung biopsy showed focal non-necrotizing granulomas with prominent eosinophilic inflammation. After discontinuation of amiodarone and initiation of systemic corticosteroid therapy, his symptoms improved rapidly and follow-up imaging demonstrated interval regression. Conclusion: This case illustrates that an OP-like CT pattern may mask an uncommon granulomatous phenotype of amiodarone-related lung injury. A positive fungal biomarker should therefore be weighed against the microbiological work-up, tissue findings, medication history, and treatment response before infection is accepted as the final diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.